Page last updated: 2024-10-24

cetylpyridinium and Mucopolysaccharidosis IV

cetylpyridinium has been researched along with Mucopolysaccharidosis IV in 2 studies

Cetylpyridinium: Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.

Mucopolysaccharidosis IV: Genetic disorder of mucopolysaccharide metabolism characterized by skeletal abnormalities, joint instability, development of cervical myelopathy, and excessive urinary keratan sulfate. There are two biochemically distinct forms, each due to a deficiency of a different enzyme.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tønnesen, T1
Gregersen, HN1
Güttler, F1
Orii, T1
Yamaguchi, M1
Minami, R1
Ito, H1
Nakao, T1

Other Studies

2 other studies available for cetylpyridinium and Mucopolysaccharidosis IV

ArticleYear
Normal MPS excretion, but dermatan sulphaturia, combined with a mild Maroteaux-Lamy phenotype.
    Journal of medical genetics, 1991, Volume: 28, Issue:7

    Topics: Adult; Cells, Cultured; Cetylpyridinium; Chondro-4-Sulfatase; Dermatan Sulfate; Diagnostic Errors; F

1991
Influence of fresh plasma infusions on patients with genetic mucopolysaccharidosis.
    The Tohoku journal of experimental medicine, 1974, Volume: 114, Issue:4

    Topics: Adolescent; Blood Transfusion; Cetylpyridinium; Child; Corneal Opacity; Creatinine; Female; Glycosam

1974